Reactive‐Oxygen‐Species‐Responsive Drug Delivery Systems: Promises and Challenges

Given the increasing evidence indicates that many pathological conditions are associated with elevated reactive oxygen species (ROS) levels, there have been growing research efforts focused on the development of ROS‐responsive carrier systems because of their promising potential to realize more spec...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Advanced science 2017-01, Vol.4 (1), p.1600124-n/a
Hauptverfasser: Saravanakumar, Gurusamy, Kim, Jihoon, Kim, Won Jong
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page n/a
container_issue 1
container_start_page 1600124
container_title Advanced science
container_volume 4
creator Saravanakumar, Gurusamy
Kim, Jihoon
Kim, Won Jong
description Given the increasing evidence indicates that many pathological conditions are associated with elevated reactive oxygen species (ROS) levels, there have been growing research efforts focused on the development of ROS‐responsive carrier systems because of their promising potential to realize more specific diagnosis and effective therapy. By judicious utilization of ROS‐responsive functional moieties, a wide range of carrier systems has been designed for ROS‐mediated drug delivery. In this review article, insights into design principle and recent advances on the development of ROS‐responsive carrier systems for drug delivery applications are provided alongside discussion of their in vitro and in vivo evaluation. In particular, the discussions in this article will mainly focus on polymeric nanoparticles, hydrogels, inorganic nanoparticles, and activatable prodrugs that have been integrated with diverse ROS‐responsive moieties for spatiotemporally controlled release of drugs for effective therapy. Based on reactive‐oxygen‐species (ROS)‐responsive materials, design principle and recent advances on the ROS‐responsive carrier systems for drug delivery systems including polymeric nanoparticles, hydrogels, inorganic nanoparticles, and activatable prodrugs are reviewed.
doi_str_mv 10.1002/advs.201600124
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5238745</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2290094707</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4622-8c7a19d8f2ee7ff7a7b8aac9ff60bba0fa22d4e33f0fb537911bcf098c2206143</originalsourceid><addsrcrecordid>eNqFkU9P20AQxVcVqCDg2mNlqRcuCbN_7F33UAklbUGKBCK0Pa7W69lg5NhhN07rWz8Cn5FPwqKECLhwmifNb57m6RHyicKQArATU67CkAHNACgTH8g-o7kacCXEzgu9R45CuIXIpFwKqj6SPaYopDyHffLnCo1dVit8-H9_8a-fYRPFdIG2whDVFYZF24S4T8a-myVjrKP2fTLtwxLn4Wty6dt5FTAkpimT0Y2pa2xmGA7JrjN1wKPNPCC_fny_Hp0NJhc_z0enk4EVGWMDZaWheakcQ5TOSSMLZYzNncugKAw4w1gpkHMHrojv55QW1kGuLGOQUcEPyLe176Ir5lhabJbe1Hrhq7nxvW5NpV9vmupGz9qVThlXUqTR4Hhj4Nu7DsNSxzgW69o02HZBU5XRVKVZpiL65Q1623a-ifE0YzlALiTISA3XlPVtCB7d9hkK-qk2_VSb3tYWDz6_jLDFn0uKAF8Df6sa-3fs9On495RKxh8BqQmntw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2290094707</pqid></control><display><type>article</type><title>Reactive‐Oxygen‐Species‐Responsive Drug Delivery Systems: Promises and Challenges</title><source>Wiley-Blackwell Open Access Titles</source><source>DOAJ Directory of Open Access Journals</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Saravanakumar, Gurusamy ; Kim, Jihoon ; Kim, Won Jong</creator><creatorcontrib>Saravanakumar, Gurusamy ; Kim, Jihoon ; Kim, Won Jong</creatorcontrib><description>Given the increasing evidence indicates that many pathological conditions are associated with elevated reactive oxygen species (ROS) levels, there have been growing research efforts focused on the development of ROS‐responsive carrier systems because of their promising potential to realize more specific diagnosis and effective therapy. By judicious utilization of ROS‐responsive functional moieties, a wide range of carrier systems has been designed for ROS‐mediated drug delivery. In this review article, insights into design principle and recent advances on the development of ROS‐responsive carrier systems for drug delivery applications are provided alongside discussion of their in vitro and in vivo evaluation. In particular, the discussions in this article will mainly focus on polymeric nanoparticles, hydrogels, inorganic nanoparticles, and activatable prodrugs that have been integrated with diverse ROS‐responsive moieties for spatiotemporally controlled release of drugs for effective therapy. Based on reactive‐oxygen‐species (ROS)‐responsive materials, design principle and recent advances on the ROS‐responsive carrier systems for drug delivery systems including polymeric nanoparticles, hydrogels, inorganic nanoparticles, and activatable prodrugs are reviewed.</description><identifier>ISSN: 2198-3844</identifier><identifier>EISSN: 2198-3844</identifier><identifier>DOI: 10.1002/advs.201600124</identifier><identifier>PMID: 28105390</identifier><language>eng</language><publisher>Germany: John Wiley &amp; Sons, Inc</publisher><subject>Disease ; drug delivery ; Drug delivery systems ; Drug dosages ; hydrogels ; inorganic nanoparticles ; Nanoparticles ; Pathogens ; polymeric nanoparticles ; prodrugs ; Radiation therapy ; reactive oxygen species ; Researchers ; Review ; Reviews</subject><ispartof>Advanced science, 2017-01, Vol.4 (1), p.1600124-n/a</ispartof><rights>2016 The Authors. Published by WILEY‐VCH Verlag GmbH &amp; Co. KGaA, Weinheim</rights><rights>2017. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4622-8c7a19d8f2ee7ff7a7b8aac9ff60bba0fa22d4e33f0fb537911bcf098c2206143</citedby><cites>FETCH-LOGICAL-c4622-8c7a19d8f2ee7ff7a7b8aac9ff60bba0fa22d4e33f0fb537911bcf098c2206143</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5238745/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5238745/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,1411,11541,27901,27902,45550,45551,46027,46451,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28105390$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Saravanakumar, Gurusamy</creatorcontrib><creatorcontrib>Kim, Jihoon</creatorcontrib><creatorcontrib>Kim, Won Jong</creatorcontrib><title>Reactive‐Oxygen‐Species‐Responsive Drug Delivery Systems: Promises and Challenges</title><title>Advanced science</title><addtitle>Adv Sci (Weinh)</addtitle><description>Given the increasing evidence indicates that many pathological conditions are associated with elevated reactive oxygen species (ROS) levels, there have been growing research efforts focused on the development of ROS‐responsive carrier systems because of their promising potential to realize more specific diagnosis and effective therapy. By judicious utilization of ROS‐responsive functional moieties, a wide range of carrier systems has been designed for ROS‐mediated drug delivery. In this review article, insights into design principle and recent advances on the development of ROS‐responsive carrier systems for drug delivery applications are provided alongside discussion of their in vitro and in vivo evaluation. In particular, the discussions in this article will mainly focus on polymeric nanoparticles, hydrogels, inorganic nanoparticles, and activatable prodrugs that have been integrated with diverse ROS‐responsive moieties for spatiotemporally controlled release of drugs for effective therapy. Based on reactive‐oxygen‐species (ROS)‐responsive materials, design principle and recent advances on the ROS‐responsive carrier systems for drug delivery systems including polymeric nanoparticles, hydrogels, inorganic nanoparticles, and activatable prodrugs are reviewed.</description><subject>Disease</subject><subject>drug delivery</subject><subject>Drug delivery systems</subject><subject>Drug dosages</subject><subject>hydrogels</subject><subject>inorganic nanoparticles</subject><subject>Nanoparticles</subject><subject>Pathogens</subject><subject>polymeric nanoparticles</subject><subject>prodrugs</subject><subject>Radiation therapy</subject><subject>reactive oxygen species</subject><subject>Researchers</subject><subject>Review</subject><subject>Reviews</subject><issn>2198-3844</issn><issn>2198-3844</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqFkU9P20AQxVcVqCDg2mNlqRcuCbN_7F33UAklbUGKBCK0Pa7W69lg5NhhN07rWz8Cn5FPwqKECLhwmifNb57m6RHyicKQArATU67CkAHNACgTH8g-o7kacCXEzgu9R45CuIXIpFwKqj6SPaYopDyHffLnCo1dVit8-H9_8a-fYRPFdIG2whDVFYZF24S4T8a-myVjrKP2fTLtwxLn4Wty6dt5FTAkpimT0Y2pa2xmGA7JrjN1wKPNPCC_fny_Hp0NJhc_z0enk4EVGWMDZaWheakcQ5TOSSMLZYzNncugKAw4w1gpkHMHrojv55QW1kGuLGOQUcEPyLe176Ir5lhabJbe1Hrhq7nxvW5NpV9vmupGz9qVThlXUqTR4Hhj4Nu7DsNSxzgW69o02HZBU5XRVKVZpiL65Q1623a-ifE0YzlALiTISA3XlPVtCB7d9hkK-qk2_VSb3tYWDz6_jLDFn0uKAF8Df6sa-3fs9On495RKxh8BqQmntw</recordid><startdate>201701</startdate><enddate>201701</enddate><creator>Saravanakumar, Gurusamy</creator><creator>Kim, Jihoon</creator><creator>Kim, Won Jong</creator><general>John Wiley &amp; Sons, Inc</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7XB</scope><scope>88I</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>M2O</scope><scope>M2P</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201701</creationdate><title>Reactive‐Oxygen‐Species‐Responsive Drug Delivery Systems: Promises and Challenges</title><author>Saravanakumar, Gurusamy ; Kim, Jihoon ; Kim, Won Jong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4622-8c7a19d8f2ee7ff7a7b8aac9ff60bba0fa22d4e33f0fb537911bcf098c2206143</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Disease</topic><topic>drug delivery</topic><topic>Drug delivery systems</topic><topic>Drug dosages</topic><topic>hydrogels</topic><topic>inorganic nanoparticles</topic><topic>Nanoparticles</topic><topic>Pathogens</topic><topic>polymeric nanoparticles</topic><topic>prodrugs</topic><topic>Radiation therapy</topic><topic>reactive oxygen species</topic><topic>Researchers</topic><topic>Review</topic><topic>Reviews</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Saravanakumar, Gurusamy</creatorcontrib><creatorcontrib>Kim, Jihoon</creatorcontrib><creatorcontrib>Kim, Won Jong</creatorcontrib><collection>Wiley-Blackwell Open Access Titles</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Advanced science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Saravanakumar, Gurusamy</au><au>Kim, Jihoon</au><au>Kim, Won Jong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reactive‐Oxygen‐Species‐Responsive Drug Delivery Systems: Promises and Challenges</atitle><jtitle>Advanced science</jtitle><addtitle>Adv Sci (Weinh)</addtitle><date>2017-01</date><risdate>2017</risdate><volume>4</volume><issue>1</issue><spage>1600124</spage><epage>n/a</epage><pages>1600124-n/a</pages><issn>2198-3844</issn><eissn>2198-3844</eissn><abstract>Given the increasing evidence indicates that many pathological conditions are associated with elevated reactive oxygen species (ROS) levels, there have been growing research efforts focused on the development of ROS‐responsive carrier systems because of their promising potential to realize more specific diagnosis and effective therapy. By judicious utilization of ROS‐responsive functional moieties, a wide range of carrier systems has been designed for ROS‐mediated drug delivery. In this review article, insights into design principle and recent advances on the development of ROS‐responsive carrier systems for drug delivery applications are provided alongside discussion of their in vitro and in vivo evaluation. In particular, the discussions in this article will mainly focus on polymeric nanoparticles, hydrogels, inorganic nanoparticles, and activatable prodrugs that have been integrated with diverse ROS‐responsive moieties for spatiotemporally controlled release of drugs for effective therapy. Based on reactive‐oxygen‐species (ROS)‐responsive materials, design principle and recent advances on the ROS‐responsive carrier systems for drug delivery systems including polymeric nanoparticles, hydrogels, inorganic nanoparticles, and activatable prodrugs are reviewed.</abstract><cop>Germany</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>28105390</pmid><doi>10.1002/advs.201600124</doi><tpages>19</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2198-3844
ispartof Advanced science, 2017-01, Vol.4 (1), p.1600124-n/a
issn 2198-3844
2198-3844
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5238745
source Wiley-Blackwell Open Access Titles; DOAJ Directory of Open Access Journals; Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
subjects Disease
drug delivery
Drug delivery systems
Drug dosages
hydrogels
inorganic nanoparticles
Nanoparticles
Pathogens
polymeric nanoparticles
prodrugs
Radiation therapy
reactive oxygen species
Researchers
Review
Reviews
title Reactive‐Oxygen‐Species‐Responsive Drug Delivery Systems: Promises and Challenges
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T18%3A17%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reactive%E2%80%90Oxygen%E2%80%90Species%E2%80%90Responsive%20Drug%20Delivery%20Systems:%20Promises%20and%20Challenges&rft.jtitle=Advanced%20science&rft.au=Saravanakumar,%20Gurusamy&rft.date=2017-01&rft.volume=4&rft.issue=1&rft.spage=1600124&rft.epage=n/a&rft.pages=1600124-n/a&rft.issn=2198-3844&rft.eissn=2198-3844&rft_id=info:doi/10.1002/advs.201600124&rft_dat=%3Cproquest_pubme%3E2290094707%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2290094707&rft_id=info:pmid/28105390&rfr_iscdi=true